Home » Topics » Regulatory

Regulatory
RSS

Nefazodone evaluated for social phobia

July 10, 1997

Preclinical and clinical antidepressant properties of tolcapone

July 10, 1997

Promising preliminary results from open trial of lamotrigine in depression

July 9, 1997

NKH-477 possesses antidepressant effects

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Dovonex cleared for use in children in the U.K.

July 9, 1997

Losec available in U.K. for symptoms of dyspepsia

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

QLT PhotoTherapeutics files for Canadian approval of lung cancer treatment

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.